Comparison of KRAS mutation analysis of colorectal cancer samples by standard testing and next-generation sequencing

Abstract

Overall there was a high concordance rate between NGS and standard testing for KRAS. However, NGS revealed mutations that are not tested for with standard KRAS assays that might have clinical impact with regards to the role for anti-EGFR therapy.